Ellipticine is primarily utilized in the field of cancer research due to its potent antitumor properties. It functions by intercalating into DNA, thereby inhibiting the replication process of cancer cells. This mechanism makes it a valuable compound in the study of potential chemotherapeutic agents. Additionally, ellipticine has been explored for its ability to inhibit topoisomerase II, an enzyme crucial for DNA replication and cell division, further enhancing its anticancer effects. Researchers are also investigating its potential in overcoming drug resistance in certain types of cancer, making it a promising candidate for future therapeutic developments.